Cargando…

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply

Detalles Bibliográficos
Autores principales:	Nonaka, Takashi, Inamori, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2011
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228991/ http://dx.doi.org/10.5056/jnm.2011.17.4.435

Ejemplares similares

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Nonaka, Takashi, et al.
Publicado: (2011)

Is the Completion Time of a Questionnaire a Pivotal Factor When Proving Feasibility?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2013)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020)

Gastric Emptying in Patients With Functional Dyspepsia and Patients With Migrain: Author's Reply
por: Jo, Yunju
Publicado: (2013)

Author’s Reply—Is it really COVID-19?
por: Chang, David, et al.
Publicado: (2020)

Effect of Glucose Control on Delayed Gastric Emptying in Diabetic Patients: Author's Reply
por: Palacio, Carlos, et al.
Publicado: (2011)

Comparison and Analysis of Delirium Induced by Histamine H(2) Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
por: Fujii, Shiro, et al.
Publicado: (2012)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
por: Kweon, Takhyeon, et al.
Publicado: (2023)

Do we really understand how faecal microbiota transplantation works? Authors' reply
por: Papanicolas, Lito E., et al.
Publicado: (2019)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

The Author's Reply: Comment on: Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control Study
por: Inamori, Masahiko, et al.
Publicado: (2018)

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs
por: Mottaghi, Batoul, et al.
Publicado: (2021)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro
por: Lepczyńska, Małgorzata, et al.
Publicado: (2021)

The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a (13)C breath test
por: Kanoshima, Kenji, et al.
Publicado: (2017)

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H(2) Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis
por: Gao, Jiamin, et al.
Publicado: (2022)

Intention to Treat Analysis: Are We Really Doing It?: Reply
por: Barczyński, Marcin
Publicado: (2013)

Prolonged Use of Proton Pump Inhibitors, but Not Histamine-2 Receptor Antagonists, Is Associated With Lower Bone Mineral Density in Males Aged Over 70
por: Gao, Shihua, et al.
Publicado: (2021)

Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review
por: Begg, Maha, et al.
Publicado: (2023)

Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B(12) Depletion
por: Zdilla, Matthew J.
Publicado: (2015)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply
por: Suzuki, Hidekazu, et al.
Publicado: (2012)

Author Reply: Lung Ultrasound Score—Does It Really Predict Extubation Failure?
por: Rajbanshi, Lalit Kumar, et al.
Publicado: (2023)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
por: Kondo, Yutaka, et al.
Publicado: (2020)

Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test
por: Nonaka, Takashi, et al.
Publicado: (2013)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)

Histamine 2 receptor antagonists do not improve the outcomes of hospitalized COVID-19 patients
por: Amjad, Waseem, et al.
Publicado: (2021)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
por: Jiang, Xin, et al.
Publicado: (2019)

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Do most radiologists in India really have a choice?
por: Sohoni, Chandrashekhar A
Publicado: (2015)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2019)

Early effects of acotiamide or mosapride intake on gastric emptying: a randomized 3-way crossover study using the (13)C breath test
por: Kaai, Megumi, et al.
Publicado: (2021)

Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.
por: Van der Ven, L. T., et al.
Publicado: (1993)

Is Otilonium Bromide Really Effective for Treating Asian Patients With Irritable Bowel Syndrome?: Author's Reply
por: Chang, Full-Young
Publicado: (2012)

Is Ramosetron Really Useful to Treat Diabetic Diarrhea With Rapid Small Bowel Transit?: Author's Reply
por: Park, Yoo Mi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6qmum6btkd4h3395eprvajsbio